Log in
Enquire now
Aktis Oncology

Aktis Oncology

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
‌
Matthew Roden
0
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...oncology
CTO
‌
Tyler Benedum
Email Address
info@aktisoncology.com
Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Biotechnology
Biotechnology
‌
Synthetic chemistry
Health technology
Health technology
Investors
ArrowMark Partners
ArrowMark Partners
MRL Ventures
MRL Ventures
Bristol-Myers Squibb
Bristol-Myers Squibb
Vida Ventures
Vida Ventures
Novartis
Novartis
Eli Lilly
Eli Lilly
MPM Capital
MPM Capital
EcoR1 Capital
EcoR1 Capital
RTW Investments LLC
RTW Investments LLC
Janus Henderson Investors
Janus Henderson Investors
•••
Latest Funding Round Date
September 30, 2024
Latest Funding Round Amount (USD)
175,000,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/aktis-oncology
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles...462974-68
Total Funding Amount (USD)
331,000,000
Official Website
aktisoncology.com

Find more companies like Aktis Oncology

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.